Followers | 98 |
Posts | 15870 |
Boards Moderated | 0 |
Alias Born | 09/13/2012 |
Tuesday, April 18, 2017 5:12:42 AM
They just release a vague statement... "working closely with"
The FDA told them they had to reactivate that 10 year old trial and do more clinical trials.
So that's what USRM has done and that's what they mean in their vague statement... "working closely with"
Of course they need money to do that and that's where GACP comes in with the committed up to maybe if
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM